Showing results (1311-1320 of 2,367) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|October 25, 2016
Recent progress of cyclin-dependent kinase inhibitors as potential anticancer agentsTinghan Li, Tianwei Weng, Minzan Zuo, et al.Future Medicinal Chemistry|October 1, 2016
Understanding PPAR-δ affinity and selectivity using hologram quantitative structure-activity modeling, molecular docking and GRID calculationsVinicius G Maltarollo, Sheila C Araujo, Gustavo H G Trossini, et al.Future Medicinal Chemistry|October 15, 2016
Activity of caffeic acid phenethyl ester in Caenorhabditis elegansJeffrey J Coleman, Tomomi Komura, Julia Munro, et al.Future Medicinal Chemistry|January 19, 2017
Practical applications of matched series analysis: SAR transfer, binding mode suggestion and data point validationPeter Hunt, Matthew Segall, Noel O'Boyle, et al.Future Medicinal Chemistry|January 19, 2017
Pseudokinases: update on their functions and evaluation as new drug targetsDominic P Byrne, Daniel M Foulkes, Patrick A EyersFuture Medicinal Chemistry|February 9, 2017
Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cellsFátima Morales, Alberto Ramírez, Cynthia Morata-Tarifa, et al.Future Medicinal Chemistry|October 20, 2022
Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapySylvain Grosjean, Irene Pachón-Angona, Michella Dawra, et al.Future Medicinal Chemistry|February 23, 2021
Triazole-containing hybrids with anti-Mycobacterium tuberculosis potential - Part I: 1,2,3-TriazoleZhenyou Tan, Jun Deng, Qiongxian Ye, et al.Future Medicinal Chemistry|August 3, 2019
Synthesis, anticancer activity, structure-activity relationship and binding mode of interaction studies of substituted pentanoic acidsSanchita Dutta, Amit Kumar Halder, Nilanjan Adhikari, et al.Future Medicinal Chemistry|August 31, 2019
The dextrans as vehicles for gene and drug deliveryShiyu Huang, Gangliang HuangPageof 237